OptimizeRx (OPRX) Gross Profit (2016 - 2026)
OptimizeRx's Gross Profit history spans 13 years, with the latest figure at $24.1 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 9.43% to $24.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.6 million, a 23.94% increase, with the full-year FY2025 number at $73.6 million, up 23.94% from a year prior.
- Gross Profit hit $24.1 million in Q4 2025 for OptimizeRx, up from $17.5 million in the prior quarter.
- Over the last five years, Gross Profit for OPRX hit a ceiling of $24.1 million in Q4 2025 and a floor of $6.1 million in Q1 2021.
- Historically, Gross Profit has averaged $12.5 million across 5 years, with a median of $12.0 million in 2024.
- Biggest five-year swings in Gross Profit: dropped 12.96% in 2023 and later surged 64.19% in 2024.
- Tracing OPRX's Gross Profit over 5 years: stood at $12.4 million in 2021, then rose by 0.51% to $12.5 million in 2022, then soared by 43.25% to $17.8 million in 2023, then grew by 23.44% to $22.0 million in 2024, then rose by 9.43% to $24.1 million in 2025.
- Business Quant data shows Gross Profit for OPRX at $24.1 million in Q4 2025, $17.5 million in Q3 2025, and $18.6 million in Q2 2025.